Second Foralumab SPMS Patient Continues to Improve & Stem Cell Transplant and Other MS News

Sep 28, 2022, 12:00 AM

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how six months of treatment with foralumab nasal spray led to significant functional improvements in the second patient with non-active SPMS.
He also reads “MS News That Caught My Eye Last Week: EBV, Stem Cell Transplant, NurOwn, Progression Without Relapse” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: https://multiplesclerosisnewstoday.com/forums/